BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31027071)

  • 21. [Liver damage detected after a hepatectomy for liver metastasis after 12 courses of mFOLFOX6 therapy as an adjuvant chemotherapy for colorectal cancer].
    Makino S; Murata K; Murakami M; Wada Y; Kato R; Nishigaki T; Owada Y; Okada K; Yanagisawa T; Okamura S; Ebisui C; Yokouchi H; Kinuta M; Nakagomi N; Tamai M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2222-4. PubMed ID: 23268030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
    Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
    World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of resection of synchronous multiple liver metastases from colorectal cancer after FOLFOX chemotherapy].
    Otsuka S; Inagaki M; Nishie M; Hamano R; Tokunaga N; Takahashi K; Tsunemitsu Y; Miyoshi K; Takahashi M; Oosaki T; Iwagaki H
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):501-4. PubMed ID: 19295281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
    Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.
    Power DG; Kemeny NE
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):251-64. PubMed ID: 20970353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A long-term survival case of liver and mediastinal LN metastases from colon cancer treated with intensive multimodal therapy].
    Nakahara O; Beppu T; Ishiko T; Mizumoto T; Masuda T; Hosaka S; Okabe H; Takamori H; Kanemitsu K; Hirota M; Baba H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1792-4. PubMed ID: 17212109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
    Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of resected rectal cancer with hepatic node and multiple liver metastases effectively treated by preoperative modified FOLFOX6 and sLV5FU2 chemotherapy].
    Seshimo K; Oishi M; Toshima T; Ikeda H; Kato H; Yamamura M; Kodera M; Yamashita Y; Tanaka N; Fujita H; Shibagaki K; Taniguchi H; Matsuki T; Kobayashi K; Takita K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):477-80. PubMed ID: 22421784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
    Uetake H; Yasuno M; Ishiguro M; Kameoka S; Shimada Y; Takahashi K; Watanabe T; Muro K; Baba H; Yamamoto J; Mizunuma N; Tamagawa H; Mochizuki I; Kinugasa Y; Kikuchi T; Sugihara K
    Ann Surg Oncol; 2015 Mar; 22(3):908-15. PubMed ID: 25465375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of sigmoid colon cancer with liver and ovarian metastases effectively treated by panitumumab after acquiring resistance to prior chemotherapy regimens].
    Honda K; Hata Y; Ihara E; Tomita Y; Miyata S; Sumida Y; Ihara Y; Misawa T
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1533-6. PubMed ID: 21918357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
    Kobayashi K; Ueki K; Ishizuka D; Wakakuwa R
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):389-91. PubMed ID: 15791824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).
    Folprecht G; Gruenberger T; Bechstein W; Raab HR; Weitz J; Lordick F; Hartmann JT; Stoehlmacher-Williams J; Lang H; Trarbach T; Liersch T; Ockert D; Jaeger D; Steger U; Suedhoff T; Rentsch A; Köhne CH
    Ann Oncol; 2014 May; 25(5):1018-25. PubMed ID: 24585720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous Polyposis.
    Toiyama Y; Inoue Y; Kitajima T; Okigami M; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Int Surg; 2014; 99(6):795-801. PubMed ID: 25437589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
    Umehara M; Umehara Y; Takahashi K; Murata A; Nishikawa S; Tokura T; Matsuzaka M; Tanaka R; Morita T
    Anticancer Res; 2016 Apr; 36(4):1949-54. PubMed ID: 27069185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
    Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
    Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Case of Conversion Surgery for Unresectable Colorectal Liver Metastases, Following Effective Combined Chemotherapy with Molecular Targeting Agents].
    Nakashima C; Suzuki N; Tomochika S; Tanaka H; Tokumitsu Y; Kanekiyo S; Tokuhisa Y; Iida M; Sakamoto K; Takeda S; Yamamoto S; Yoshino S; Hazama S; Ueno T; Nagano H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1272-1274. PubMed ID: 29394604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy].
    Yoshida R; Matsuura T; Hijikawa K; Yanagida H; Kitade H; Takada H; Kwon AH
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1575-7. PubMed ID: 23064076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A Case of Neuroendocrine Carcinoma of the Ascending Colon That Responded Completely to Chemotherapy].
    Satake M; Yoshimatsu K; Ito Y; Imaizumi R; Sano M; Kodera A; Miyano Y; Koike T; Yamada Y; Okayama S; Yokomizo H; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1513-1515. PubMed ID: 30382062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Case of Pathological Complete Response of Colon Cancer after Systemic Chemotherapy with mFOLFOX6].
    Otani A; Inoue M; Otani T; Watanabe N; Hayashi T
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1750-1752. PubMed ID: 33468817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
    Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
    Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.